Warren Lucinda 4
4 · Cue Biopharma, Inc. · Filed Nov 25, 2025
Insider Transaction Report
Form 4
Warren Lucinda
CHIEF BUSINESS OFFICER
Transactions
- Award
Stock Option (right to buy)
2025-09-29+125,000→ 125,000 totalExercise: $0.72Exp: 2035-09-28→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]This stock option becomes fully exercisable on the first anniversary of the grant date.